Acción CLSR.B CLINICAL LASERTHERMIA SYSTEMS AB
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas Clinical Laserthermia Systems AB Swiss Exchange

Acciones

CLSR.B

SE0002756130

Precio de cierre Swiss Exchange
Otros sitios de cotización
- SEK - Gráfico intradía de Clinical Laserthermia Systems AB
31/05 Clinical Laserthermia Systems recaudará 59 millones de coronas suecas mediante una emisión de derechos MT
29/05 Clinical Laserthermia Systems AB (publ) informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
CLS publishes prospectus in connection with forthcoming rights issue
Clinical Laserthermia Systems publishes annual report for 2023
BioStock: CLS' partner initiates full market release in the US
First Clinical Data from the Investigator-initiated study with CLS Focal Laser Ablation system at the University Hospital Magdeburg will be presented at the Nordkongress in Lübeck 13-15 June 2024
CLS presents its new strategic direction in a Business Update Event on June 12
CLS Commercial Partner is Initiating Full Market Release of ClearPoint Prism 3T Neuro Laser Therapy System in The U.S
Clinical Laserthermia Systems to Raise SEK59 Million via Rights Issue
CLS resolves on a partially guaranteed Rights Issue of approximately SEK 59m
CLS publishes interim report January - March 2024
Clinical Laserthermia Systems AB Reports Earnings Results for the First Quarter Ended March 31, 2024
Notice of Annual General Meeting of Clinical Laserthermia Systems AB June 28 2024
BioStock: CLS revises strategy - increases focus on neurosurgery
CLS focuses on the Neurosurgery business area to optimize capital allocation, secure profitability targets and implement associated cost savings
BioStock: CLS launches in France
CLS launches its Focal Laser Ablation system for prostate cancer in France in collaboration with MTEC Company
Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with MTEC Company
Clinical Laserthermia Notes US FDA Clearance for ClearPoint's Prism Bone Anchor Accessory
CLS partner ClearPoint Neuro receives FDA 510(k) clearance for Prism Bone Anchor Accessory enabling operating room placement of laser applicators
Clinical Laserthermia Systems announces timetable and additional information for the upcoming reverse share split
Bulletin from the Extraordinary General Meeting on Friday 12th of April in Clinical Laserthermia Systems AB
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción CLS B
  4. Acción CLSR.B
  5. Noticias Clinical Laserthermia Systems AB
  6. Otros idiomas